Previous close | 14.05 |
Open | 14.05 |
Bid | 15.40 |
Ask | 15.75 |
Strike | 130.00 |
Expiry date | 2022-11-18 |
Day's range | 14.05 - 14.05 |
Contract range | N/A |
Volume | |
Open interest | 73 |
Today's Research Daily features new research reports on 12 major stocks, including JPMorgan Chase & Co. (JPM), AbbVie Inc. (ABBV) and Abbott Laboratories (ABT).
I-Mab's (IMAB) partner AbbVie decides to stop early-stage development of an anti-CD47 antibody therapy targeting multiple cancer indications. IMAB intends to support the candidate's development.
You'll need to hold these stocks for many years to get the full benefit of their consistent dividend growth.